Stock NNVC NANOVIRICIDES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus NanoViricides, Inc.

Equities

NNVC

US6300873022

Market Closed - Nyse
Other stock markets
 04:10:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.1 USD -0.90% Intraday chart for NanoViricides, Inc. 0.00% +7.84%
Feb. 14 NanoViricides, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Feb. 01 NanoViricides, Inc. Announces Clinical Trial Demonstration of Safety and Tolerability of NV-CoV-2 Has Implications Beyond COVID Treatment, Explains NanoViricides - NV-387 Could be As Revolutionary as Antibiotics CI

Evolution of the average Target Price on NanoViricides, Inc.

Price target over the last 5 years

History of analyst recommendation changes

db5d63fe42aff5e05fad1457.d_ZIBYAN3GIN8McrXwuadeJ2uh89KjPcWNe9MYXhT5o.QJkPX7lKnQc6tr54GXHVAKc1jlEJTHrlNrKPB-mqfesFji5C1Xy7J0XItA~08e4e185b91bb30ab3dca630fcb9f5d2

Analyst Recommendations on NanoViricides, Inc.

EF Hutton Lowers Price Target on NanoViricides to $5.25 From $8.50, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.1 USD
Average target price
6.5 USD
Spread / Average Target
+490.91%
High Price Target
6.5 USD
Spread / Highest target
+490.91%
Low Price Target
6.5 USD
Spread / Lowest Target
+490.91%

Consensus detail

Consensus revision (last 18 months)

Analysts covering NanoViricides, Inc.

EF Hutton

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NNVC Stock
  4. Consensus NanoViricides, Inc.